These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 11191692

  • 1. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults.
    Taylor FB, Russo J.
    J Child Adolesc Psychopharmacol; 2000; 10(4):311-20. PubMed ID: 11191692
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
    Biederman J, Swanson JM, Wigal SB, Kratochvil CJ, Boellner SW, Earl CQ, Jiang J, Greenhill L.
    Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
    [Abstract] [Full Text] [Related]

  • 3. Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation.
    Swanson JM, Greenhill LL, Lopez FA, Sedillo A, Earl CQ, Jiang JG, Biederman J.
    J Clin Psychiatry; 2006 Jan; 67(1):137-47. PubMed ID: 16426100
    [Abstract] [Full Text] [Related]

  • 4. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder.
    Kahbazi M, Ghoreishi A, Rahiminejad F, Mohammadi MR, Kamalipour A, Akhondzadeh S.
    Psychiatry Res; 2009 Aug 15; 168(3):234-7. PubMed ID: 19439364
    [Abstract] [Full Text] [Related]

  • 5. A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study.
    Biederman J, Swanson JM, Wigal SB, Boellner SW, Earl CQ, Lopez FA, Modafinil ADHD Study Group.
    J Clin Psychiatry; 2006 May 15; 67(5):727-35. PubMed ID: 16841622
    [Abstract] [Full Text] [Related]

  • 6. Effect size of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.
    Wigal T, Brams M, Gasior M, Gao J, Giblin J.
    Postgrad Med; 2011 Mar 15; 123(2):169-76. PubMed ID: 21474905
    [Abstract] [Full Text] [Related]

  • 7. Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study.
    Boellner SW, Earl CQ, Arora S.
    Curr Med Res Opin; 2006 Dec 15; 22(12):2457-65. PubMed ID: 17257460
    [Abstract] [Full Text] [Related]

  • 8. Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder.
    Taylor FB, Russo J.
    J Clin Psychopharmacol; 2001 Apr 15; 21(2):223-8. PubMed ID: 11270920
    [Abstract] [Full Text] [Related]

  • 9. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
    Coghill D, Banaschewski T, Lecendreux M, Soutullo C, Johnson M, Zuddas A, Anderson C, Civil R, Higgins N, Lyne A, Squires L.
    Eur Neuropsychopharmacol; 2013 Oct 15; 23(10):1208-18. PubMed ID: 23332456
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder.
    Findling RL, Childress AC, Cutler AJ, Gasior M, Hamdani M, Ferreira-Cornwell MC, Squires L.
    J Am Acad Child Adolesc Psychiatry; 2011 Apr 15; 50(4):395-405. PubMed ID: 21421179
    [Abstract] [Full Text] [Related]

  • 11. The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study.
    Childress AC, Brams M, Cutler AJ, Kollins SH, Northcutt J, Padilla A, Turnbow JM.
    J Child Adolesc Psychopharmacol; 2015 Jun 15; 25(5):402-14. PubMed ID: 25692608
    [Abstract] [Full Text] [Related]

  • 12. Clinical utility of ADHD symptom thresholds to assess normalization of executive function with lisdexamfetamine dimesylate treatment in adults.
    Brown TE, Brams M, Gasior M, Adeyi B, Babcock T, Dirks B, Scheckner B, Wigal T.
    Curr Med Res Opin; 2011 Jun 15; 27 Suppl 2():23-33. PubMed ID: 21973229
    [Abstract] [Full Text] [Related]

  • 13. Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal design.
    Brams M, Weisler R, Findling RL, Gasior M, Hamdani M, Ferreira-Cornwell MC, Squires L.
    J Clin Psychiatry; 2012 Jul 15; 73(7):977-83. PubMed ID: 22780921
    [Abstract] [Full Text] [Related]

  • 14. Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study.
    Adler LA, Dirks B, Deas PF, Raychaudhuri A, Dauphin MR, Lasser RA, Weisler RH.
    J Clin Psychiatry; 2013 Jul 15; 74(7):694-702. PubMed ID: 23945447
    [Abstract] [Full Text] [Related]

  • 15. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
    Najib J.
    Clin Ther; 2009 Jan 15; 31(1):142-76. PubMed ID: 19243715
    [Abstract] [Full Text] [Related]

  • 16. Relationship of ADHD symptoms and global illness severity in adults treated with lisdexamfetamine dimesylate.
    Weisler RH, Babcock T, Adeyi B, Brams M.
    Postgrad Med; 2014 Sep 15; 126(5):31-41. PubMed ID: 25295648
    [Abstract] [Full Text] [Related]

  • 17. Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder.
    Turner DC, Clark L, Dowson J, Robbins TW, Sahakian BJ.
    Biol Psychiatry; 2004 May 15; 55(10):1031-40. PubMed ID: 15121488
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 15; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 19. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
    Biederman J, Pliszka SR.
    J Pediatr; 2008 Mar 15; 152(3):394-9. PubMed ID: 18280848
    [Abstract] [Full Text] [Related]

  • 20. A randomised, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder.
    Paterson R, Douglas C, Hallmayer J, Hagan M, Krupenia Z.
    Aust N Z J Psychiatry; 1999 Aug 15; 33(4):494-502. PubMed ID: 10483843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.